Healthcare Financial News

Hero MotoCorptouched all-time high levels on Tuesday's session. The other stocks that ended in green were Hindustan Unilever Ltd (HUL), Dabur India Ltd, Sun TV Network Ltd, Colgate-Palmolive (India) Ltd, Avenue Supermarts Ltd, United Breweries Ltd, Nestle India Ltd, Godrej Consumer Products Ltd, Pidilite Industries Ltd, United Spirits Ltd, Max Healthcare Institute Ltd, Procter & Gamble Hygiene & Healthcare Ltd, Abbott India Ltd, Tata Consumer Products Ltd, Page Industries Ltd, and UTI Asset Management Company Ltd.The real counting of ballots today (Tuesday, June 4) indicates, in contrast to exit polls based on sample data, that Modi's NDA has a considerably weaker mandate.

companies such as PFC, REC Ltd and Adani Ports suffered the worst hit in today's market mayhem which witnessed a massive selloff on the back of a poor showing by the Narendra Modi led NDA in the Lok Sabha elections, results for which were trickling in early in the day. PFC and REC Ltd fell nearly 20% to Rs 443.85 and Rs 485 respectively while companies like HUDCO, Adani Energy Solutions, Adani Green Energy, Titagargh Rail and Adani Total Gas also witnessed an over 15% crash so far in the day.

Sensex and Nifty tanked nearly 4% to the day's low of 73,659.29 and 22,389.85 respectively on Tuesday, with early trends suggesting a fightback by the India alliance albeit a majority mark for the NDA alliance, certain sectors managed to hold themselves as others witnessed a free fall. While Sensex slipped from Monday's closing of 76,468.78 by 2809 points on the intraday basis, the broader Nifty witnessed an 874 point fall to 23,263.90.

Tata Motors, and Coal India, contributed 72% of the incremental YoY accretion in earnings. Ex-Metals and Oil & Gas, Nifty’s earnings grew 16% YoY.Read Election Results 2024 Live Updates hereNifty earnings per share (EPS) for FY24 increased 2.6% to ₹1,005 from ₹980 earlier, largely fueled by notable upgrades in ONGC, Coal India, and SBI. EPS for FY25E and FY26E also experienced upward revisions of 0.8% each to ₹1,142 and ₹1,327, according to brokerage firm Motilal Oswal.

Apollo Hospitals, Fortis Healthcare, Max Healthcare, Narayana Hrudayalaya (NHL) and Aster DM Healthcare — have reported an increase in average revenue per operating bed (ARPOB), improved operational efficiency and capex plans to expand. Here are the key takeaways from their performance in the latest quarter through March:

Mint in detail about his perspective on the markets and on investing. Edited excerpts: The term "long term" has been misused in recent market runs. For traditional investors focusing on generational wealth through equities, long term means beyond three to five years.

HealthCare Global Enterprises Limited (“HCG"),the leader in India in speciality healthcare services focused on oncology and fertility today announced its audited financial results for the quarter (“Q4")and full year ended FY24.Highlights for quarter endedMarch 31st, 2024INR million except earnings per sharePeriod ended Mar’24Q4-FY24Q4-FY23(1)Growth(y-o-y)4,9464,41712%94177821%19.0%17.6%92076321%18.6%17.3%282131115%5.7%3.0%21384154%4.3%1.9%1.50.6(1) Q4 FY23 includes Revenue & EBITDA from discontinued MSR operations, adjusted Revenue growth stands at 14% &EBITDA growth stands at 23%(2) Adjusted EBITDA excluding ESOPs and Onetime Expense(3) PAT after Minority InterestCommenting on the results,Dr. B.S. Ajaikumar, Executive Chairman, HealthCare Global Enterprises Ltd.said,“We experience a deep sense of fulfilment to report a consistent benchmark-beating performance across all fronts for the quarter and the fiscal year ending FY24. Year after year, HCG has achieved sustainable cancer care outcomes comparable to premier centers in the world, thanks to our unique value-based care model and focused factory approach providing patients with the right treatment at the right time, using best in class talent, knowledge, technology, and infrastructure.Given the mounting incidence of cancer in recent years, India has prudently enhanced its cancer diagnosis and treatment processes in the guiding light of visionary crusaders like HCG. We prioritize a deep engagement in academics and research alongside an unflinching focus on patient outcomes. In the past year, we have made significant triumphs, including the successful completion if comprehensive genomic profiling for over 1,000 cancer patients, executing complex surgeries, and launching

Mint.“We’re very bullish on India’s growth story. One of the biggest advancements I have seen is that infrastructure is improving and the economy is growing robust which has led to the emergence of innovative companies, especially in deeptech," Chaturvedi said.Hades—which is sector-agnostic—invests directly in companies and indirectly through fund managers.

election in India is seen solely as a numbers game. The obsession with rally size, voter turnout, number of campaign rallies, vote shares, seats won, etc, is especially big deal in Lok Sabha elections. But now that the hurly-burly's done — and the battle's almost lost and won — it's time to look beyond the nose of quantity and think of whether the quality of this democratic exercise may be strained.

1. Lifestyle modifications: Managing PCOS starts with lifestyle changes. Losing even 10% of excess weight can help restore normal ovulation and improve fertility in women with PCOS.

The new to health individuals, represented by young adults and Gen Z, are today demonstrating a forward-thinking and practical approach to financial matters, understanding the importance of long-term financial well-being. Amid their daily personal and work responsibilities, taking care of their health has become a top priority. As a financially savvier younger generation they see health insurance as a vital financial investment to protect their physical and financial wellbeing. Also Read:How can global health insurance improve your travel experience?

₹1.28 for Q4 which increased by 113.32% Y-o-Y. Healthcare Global Enterprises has delivered -0.28% return in the last 1 week, -3.16% return in the last 6 months and -2.05% YTD return.Currently, Healthcare Global Enterprises has a market cap of ₹4986.57 Cr and 52wk high/low of ₹401 & ₹306 respectively.

Also Read: IPO Boom: 57% of SME issues saw over 100% subscription in 2024, HOAC Foods leads pack; check top performersAnalysts believe that the rise in IPO activity has been driven by the strong economic development, rising Indian stocks, and consistently exceeding expectations of company earnings, which encourages more companies to go public. The IPO market has benefited greatly as a consequence, and new –age companies like Tata Capital, Hexaware, Ola Electric, and Swiggy are lining up for their 2024–2025 public market debuts.“The primary market witnessed 30 mainboard IPOs till May this year.

Top Gainers and Losers in the Nifty Index TodayThe top gainers in the Nifty index today were Adani Enterprises (up 6.80%), Adani Ports & Special Economic Zone (up 3.90%), Shriram Finance (up 2.23%), Coal India (up 1.88%), and Tata Steel (up 1.86%). On the other hand, the top losers in the Nifty index were Divis Laboratories (down 2.39%), Nestle India (down 2.08%), Tata Consultancy Services (down 1.74%), Maruti Suzuki India (down 1.58%), and LTI Mindtree (down 1.49%).The bank nifty ended at 48,682.35, with an intraday high of 49,122.55 and a low of 48,569.05.

₹1.49 for Q4, marking a 14.58% increase year-over-year. This positive EPS growth reflects well on the company's profitability.Shalby's stock performance has shown mixed results with -0.7% return in the last week, -12.01% return in the last 6 months, and -10.67% Year-to-Date return, reflecting market volatility.With a market capitalization of ₹2897.41 Cr and a 52-week high/low of ₹339.5 & ₹136.5 respectively, Shalby continues to be a prominent player in the healthcare sector.Analysts covering Shalby have provided positive ratings, with 1 analyst giving a Buy rating and 1 analyst giving a Strong Buy rating as of 31 May, 2024.

Apollo Hospitals on Thursday reported a 76% year-on-year (YoY) jump in net profit to Rs 254 crore in Q4FY24, led by growth across the hospital, diagnostics, speciality and pharmacies businesses. The company reported a net profit of Rs 145 crore in the corresponding quarter of the previous year.

₹253.8 crore for the quarter ended March, a 76% rise from the corresponding three months a year ago, buoyed by a continued reduction in losses at its pharmacy, health and lifestyle segments.During Q4, it reported revenues of ₹4,944 crore, a 15% y-o-y rise from ₹4,302.2 crore. The results were in line with Bloomberg analyst estimates.“The increase in PAT is not just attributable to the revenues but also significantly to the improving overall profitability of HealthCo, on which we have been working to break even quarter on quarter.

Also Read- Lok Sabha Elections 2024: Defence, power, industrials among sectors to bet on ahead of election resultAnshuman Arzare MD CEO of Yes Securities said that before election results, investors should adopt a strategy of diversifying their portfolios across various sectors to mitigate risk. Focusing on defensive stocks, such as those in the FMCG (Fast moving Consumer Goods), healthcare, and utilities sectors, can provide stability and reduce volatility.Additionally, maintaining a portion of the portfolio in cash or liquid assets can enable investors to capitalize on market corrections, with buying during dips being a potentially fruitful strategy, suggests Arzare.After the election results, investors need to assess the new government's policies and their potential impact on different sectors as per Arzare.

Welcome to Elixir Reserve-2.Situated in the heart of the city, Elixir Reserve-2 offers easy access to both the eastern and western parts of Mumbai. Located adjacent to JVLR, commuting to the western side is seamless. The upcoming Metro station, just half a kilometre away, further enhances accessibility, making Elixir Reserve-2 the best choice for those seeking both luxury and connectivity.Elixir Reserve-2 promises a lifestyle where serenity and urban living coexist harmoniously.

equity indices traded lower for the fifth consecutive session on Thursday, dragged down by metal and IT stocks, as investors refrained from making big bets ahead of the outcome of national elections early next week. The BSE Sensex was trading 202 points, or 0.27%, lower at 75,301. The Nifty50 was down 60 points, or 0.27%, trading at 22,644 around 9:19 am.

Aster DM Healthcare with a target price of Rs 400. The current market price of Aster DM Healthcare Ltd. is Rs 366.9. Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 18247.21 Crore) operating in Hospitals & Allied Services sector.